Humanized chondroitinase ABC sensitizes glioblastoma cells to temozolomide
Alena Cristina Jaime‐Ramirez(The Ohio State University), Balveen Kaur(Augusta University), Nina Dmitrieva(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Jeffrey Wojton(The Ohio State University Wexner Medical Center), Yeshavanth Banasavadi‐Siddegowda(Neurological Surgery), Theresa Relation(Neurological Surgery), Ji Young Yoo(The University of Texas MD Anderson Cancer Center), Jianying Zhang(Inner Mongolia Agricultural University), Chelsea Bolyard(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute)
Cited by 50
Related Papers
Cyclophosphamide enhances glioma virotherapy by inhibiting innate immune responses
|Proceedings of the National Academy of Sciences|2006|360
Glucose-Mediated N-glycosylation of SCAP Is Essential for SREBP-1 Activation and Tumor Growth
|Cancer Cell|2015|336
Inhibition of SOAT1 Suppresses Glioblastoma Growth via Blocking SREBP-1–Mediated Lipogenesis
|Clinical Cancer Research|2016|332
VEGF-specific Short Hairpin RNA–expressing Oncolytic Adenovirus Elicits Potent Inhibition of Angiogenesis and Tumor Growth
|Molecular Therapy|2007|150
RNA Nanoparticle-Based Targeted Therapy for Glioblastoma through Inhibition of Oncogenic miR-21
|Molecular Therapy|2017|147